Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Johan Richter

ResearcherPublications, citations & collaboration network

Johan Richter is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 279 works, 8,908 citations, an h-index of 47 and an i10-index of 125.

279
Works
8,908
Citations
47
h-index
125
i10-index

How has Johan Richter's publication output changed over time?

ScholarIQpublication output · 1990–2020

Output grew100% over the shown period — from 1 works in 1990 to 2 in 2020.

1
1
1
1
2
2
1
2
19902007201020112016201720182020

What are the most-cited papers on Johan Richter?

ScholarIQmost cited works
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann
S149476849. 20201,531 CitationsOPEN ACCESS
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
Susanne Saußele, Johan Richter, Joëlle Guilhot, Franz Gruber, Henrik Hjorth-Hansen, António Almeida, Jeroen J. W. M. Janssen, Jiřı́ Mayer, Perttu Koskenvesa, Panayiotis Panayiotidis, Ulla Olsson‐Strömberg, Joaquín Martínez‐López, Philippe Rousselot, Hanne Vestergaard, Hans Ehrencrona, Veli Kairisto, Kateřina Machová Poláková, Martin C. Müller, Satu Mustjoki, Marc Berger, Alice Fabarius, Wolf‐Karsten Hofmann, Andreas Hochhaus, Markus Pfirrmann, François‐Xavier Mahon, Gert J. Ossenkoppele, Maria Pagoni, Stina Söderlund, Martine Escoffre‐Barbe, Gabriel Étienne, Jolanta Dengler, Françoise Huguet, Nikolas von Bubnoff, Hana Klamová, Edgar Faber, François Guilhot, Kourosh Lotfi, Delphine Réa, Tim H. Brümmendorf, G.E. de Greef, Leif Stenke, Franck E. Nicolini, Laurence Legros, Andreas Burchert, J Voglová, Aude Charbonnier, Emmanuel Gyan, Volker Kunzmann, Peter E. Westerweel
The Lancet Oncology. 2018615 CitationsOPEN ACCESS
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Andreas Hochhaus, Susanne Saußele, Gianantonio Rosti, F-X Mahon, J. Janssen, Henrik Hjorth‐Hansen, Johan Richter, Christian Buske
Annals of Oncology. 2017345 Citations
The concept of treatment-free remission in chronic myeloid leukemia
Susanne Saußele, Johan Richter, Andreas Hochhaus, F-X Mahon
S149476849. 2016252 CitationsOPEN ACCESS
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Mette Ilander, Ulla Olsson‐Strömberg, Heinrich Schlums, Joëlle Guilhot, Oscar Brück, Hanna Lähteenmäki, Tiina Kasanen, Perttu Koskenvesa, S Söderlund, Martin Höglund, Berit Markevärn, Anders Själander, Kourosh Lotfi, Arta Dreimane, Anna Lübking, Elena Holm, Mats Björeman, Sören Lehmann, Leif Stenke, Lotta Ohm, Tobias Gedde‐Dahl, Waleed Majeed, Hans Ehrencrona, Satu Koskela, Susanne Saußele, F-X Mahon, Kimmo Porkka, Henrik Hjorth‐Hansen, Yenan T. Bryceson, Johan Richter, Satu Mustjoki
S149476849. 2016248 CitationsOPEN ACCESS

Related on ScholarIQ

Lund University
Institution
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Paper
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
Paper
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paper
The concept of treatment-free remission in chronic myeloid leukemia
Paper
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Paper
470M+ articles · free account